Calcium dobesilate possesses antioxidant properties and protects against ca
pillary permeability by reactive oxygen species in the rat peritoneal cavit
y, but whether a similar action can take place in the diabetic rat retina i
s unknown. We investigated the oral treatment of diabetic rats with calcium
dobesilate on the prevention of free radical-mediated retinal injury induc
ed by ischemia/reperfusion (90 min ischemia followed by 3 min and/or 24 h o
f reperfusion). Streptozotocin-induced diabetic rats were orally treated wi
th 50 and 100 mg/kg of calcium dobesilate for 10 days (n = 12 in each group
). In the first series of studies, calcium dobesilate was found to signific
antly reduce the maldistribution of ion content in diabetic ischemic/reperf
used rat retina. Thus, in diabetic rats treated with 100 mg/kg/day calcium
dobesilate, ischemia/reperfusion provoked: (i) 27.5% increase in retinal Na
+ content compared to 51.8% in the vehicle-treated group (P < 0.05), and (i
i) 59.6% increase in retinal Ca2+ content compared to 107.1% in vehicle-tre
ated animals (P < 0.05). In the second series of studies, calcium dobesilat
e was found to significantly protect diabetic rat retina against inhibition
of Na+/K+-ATPase and Ca2+/Mg2+-ATPase activities by ischemia/reperfusion (
54% and 41% reduction, respectively, with 100 mg/kg of calcium dobesilate)
and also against changes in retinal ATP, reduced glutathione (GSH), and oxi
dized glutathione (GSSG) contents. In the third series of experiments, rats
treated with 100 mg/kg of calcium dobesilate reduced the hydroxyl radical
signal intensity to 41% (measured by electron paramagnetic resonance), indu
ced by ischemia/reperfusion in diabetic rat retina. Finally, 100 mg/kg calc
ium dobesilate significantly reduced retinal edema (measured by the thickne
ss of the inner plexiform. layer) in diabetic rats. In conclusion, oral tre
atment with calcium dobesilate significantly protected diabetic rat retina
against oxidative stress induced by ischemia/reperfusion. Whether the antio
xidant properties of calcium dobesilate explain, at least in part, its bene
ficial therapeutic effects in diabetic retinopathy deserves further investi
gation. (C) 2001 Elsevier Science B.V. All rights reserved.